Shakeel Kahn, Petitioner v. United States
Case Number:
21-5261
Court:
Nature of Suit:
Firms
Companies
Sectors & Industries:
-
November 06, 2023
Justices Rebuff Opioid Doctor's Quest For 2nd Round
The U.S. Supreme Court denied a petition Monday from an Alabama opioid prescriber who asked the justices to review whether lower courts have ignored the tougher prosecution standard established in his own Supreme Court case.
-
June 27, 2023
Supreme Court's Opioid Edict Spawns 'Troubling' Divisions
Against long odds, two doctors facing decades in prison implored the U.S. Supreme Court to harmonize jury instructions in opioid crisis prosecutions, insisting that innocence in one circuit could be guilt in another. They ultimately prevailed, but one year later, the circuit split surprisingly appears even starker, as one of the doctors eyes freedom, and the other still might live out his life behind bars.
-
February 03, 2023
10th Circ. Erases CSA Convictions After High Court Ruling
The Tenth Circuit on Friday vacated the Controlled Substances Act convictions of a doctor accused of excessively prescribing opioids and other addictive drugs, after the U.S. Supreme Court ruled in his favor.
-
October 11, 2022
DOJ Overhauls Walmart Opioid Suit After High Court Decree
Amid the U.S. Supreme Court's new standards for Controlled Substances Act cases, the U.S. Department of Justice is striving to salvage a sweeping suit targeting Walmart's sales of prescription narcotics, insisting that company officials "routinely ignored" their own suspicions about opioid orders.
-
September 02, 2022
The Hottest Topics For Health Attys In 2022's Homestretch
A torrid 2022 for health care litigation is entering a red-hot homestretch featuring fallout from the U.S. Supreme Court's explosive repudiation of abortion rights, the potential for three False Claims Act clashes at the high court, and the increasingly likely prospect of a funding fiasco for the U.S. Food and Drug Administration.
-
July 21, 2022
The Rulings That Quickly Made 2022 Huge For Health Law
A spree of remarkable rulings has already made 2022 a jaw-dropping year for health care and pharmaceutical law, where the U.S. Supreme Court reshaped abortion rights, opioid crisis prosecutions, Medicare's rulemaking powers and vital sources of hospital income. At the midyear mark, Law360 recaps the rulings and analyzes their implications.
-
June 28, 2022
High Court's CSA Decree Augurs Opioid Upheaval For DOJ
The U.S. Supreme Court's demand for a rock-solid showing of intentional impropriety when federal opioid prosecutors target pills-for-profits schemes under the Controlled Substances Act will send the U.S. Department of Justice scrambling to salvage its less sensational suits, attorneys say.
-
June 27, 2022
Prescriber Intent Matters In Opioid Cases, High Court Rules
Prosecutions under the Controlled Substances Act for the excessive prescribing of opioids and other addictive drugs must show that doctors knew they lacked a legitimate medical purpose, the U.S. Supreme Court ruled Monday in a defeat for the U.S. Department of Justice.
-
June 13, 2022
Justices Spurn Insys Exec's Appeal In Landmark Opioid Case
The U.S. Supreme Court said Monday it would not hear an appeal by John Kapoor, the founder of Insys Therapeutics Inc., challenging his conviction for orchestrating a scheme to bribe doctors to prescribe a powerful opioid spray.
-
May 16, 2022
Insys Founder Says Looming Opioid Ruling Boosts Appeal
The founder of Insys Therapeutics Inc. told the U.S. Supreme Court that a pending high court ruling could undo his conviction for orchestrating a scheme to bribe doctors to prescribe a powerful opioid spray.